Ionis Pharmaceuticals, Inc.
IONS
$72.33
-$0.01-0.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -78.37% | -204.09% | 184.08% | -40.81% | 25.72% |
| Total Depreciation and Amortization | 63.06% | -17.46% | 1.06% | 2.47% | -4.11% |
| Total Amortization of Deferred Charges | 19.13% | 0.36% | 0.24% | -1.91% | -0.24% |
| Total Other Non-Cash Items | 1,738.30% | -107.26% | 62.28% | -28.97% | 59.29% |
| Change in Net Operating Assets | 540.72% | 81.00% | 30.82% | 32.92% | -625.68% |
| Cash from Operations | -4.77% | -186.85% | 200.37% | -29.82% | -1.00% |
| Capital Expenditure | -304.02% | 57.17% | 2.16% | 50.67% | -181.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -512.19% | 189.65% | -158.88% | 95.32% | 128.25% |
| Cash from Investing | -559.29% | 176.07% | -170.44% | 149.89% | 120.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -652,807.32% | -2.50% | 4.76% | 99.91% | -92,702.08% |
| Issuance of Common Stock | 32.68% | 6,213.83% | -42.57% | 422.38% | -99.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 627.89% | 6,413.07% | -43.29% | 104.98% | -108.89% |
| Foreign Exchange rate Adjustments | 47.56% | -113.78% | 156.47% | 147.74% | -238.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.35% | 23.93% | 49.73% | 123.90% | -327.83% |